RxDoctor Payments Data

Kim Haynes-Henson, MD

Anesthesiology · Omaha, NENPI 1487605697

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Among anesthesiology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,041in general payments, 2019–2025

Across 46 payments — averaging $87.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$926
  • Abbott$922
  • Nevro Corp.$701
  • Stimwave Technologies Incorporated$425
  • Boston Scientific$336
  • Saluda Medical Americas, Inc.$148
  • plus $583 from 6 others

What the payments were for

  • Food & beverage$4,041100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,041 in reported general payments places this provider in the 95th percentile of 281 anesthesiology providers in Nebraska.

See all anesthesiology providers in Nebraska

Medicare billing

Part B allowed, 2024
$60,276
Medicare patients
167
Services billed
649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe19$13,754
ZubsolvBuprenorphine Hcl/Naloxone Hcl11$6,336
Pregabalin90$3,094
Duloxetine Hcl57$879
Gabapentin55$855
RizatriptanRizatriptan Benzoate11$646
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl17$567
Celecoxib15$386
Naltrexone Hcl18$373
Tizanidine Hcl15$296
Nortriptyline Hcl20$205
Topiramate57$200
Sumatriptan Succinate11$197
Methocarbamol12$173
Meloxicam47$165

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →